Form 4 for FATE FATE THERAPEUTICS INC
Accepted 2021-08-20 00:00:00 ET · period of report 2021-08-19 · accession 0001209191-21-052744 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-20 | 2021-08-19 | FATE | Wolchko J Scott | Pres, CEO, Dir | M - OptEx | $4.84 | +20.0K | 413.8K | +5% | +$96.8K |
| D | 2021-08-20 | 2021-08-19 | FATE | Wolchko J Scott | Pres, CEO, Dir | S - Sale+OE | $88.01 | -20.0K | 393.8K | -5% | -$1.76M |
| D | 2021-08-20 | 2021-08-19 | FATE | Wolchko J Scott | Pres, CEO, Dir | M - OptEx | $0.00 | -20.0K | 4,846 | -80% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-19 | M | A | 20,000 | $4.84 | 413,793 | D | — | — | |
| 2 | Common | Common Stock | 2021-08-19 | S | D | 20,000 | $88.01 | 393,793 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2021-08-19 | M | D | 20,000 | $0.00 | 4,846 | D | $4.84 · — to 2025-01-04 | 20,000 Common Stock | (F2) This option is fully vested. |